{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:24Z","timestamp":1787022084200,"version":"build-2736575974"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T00:00:00Z","timestamp":1619395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1107043"],"award-info":[{"award-number":["APP1107043"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009321","name":"icare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009321","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sir Charles Gairdner Hospital Research Advisory Committee"},{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Institute of Respiratory Health"},{"name":"Insurance Commission of Western Australia"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>\n                    Predicting survival of patients with malignant pleural effusions (MPEs) is notoriously difficult. A robust prognostic marker can guide clinical decision making. The neutrophil-to-lymphocyte ratio (NLR) in blood has been shown to predict survival in many cancers. Pleural fluid bathes the malignant pleural tissues, thus the NLR of the pleural fluid may reflect more closely the local tumour environment. The objective of this study was to explore the prognostic significance of pleural effusion NLR for MPE. We analysed matched effusion and blood from 117 patients with malignant and 24 with benign pleural effusions. Those who had received recent chemotherapy or had a pleurodesis were excluded. Neutrophil and lymphocyte counts in effusions were performed by manual review of cytospin cell preparations by trained observers. Clinical data were extracted from a state-wide hospital database. We found significantly fewer neutrophils (expressed as percentage of total leukocyte count) in pleural fluid than in corresponding blood (9% vs 73%; p&lt;0.001). The NLR was an order of magnitude lower in pleural fluid than in corresponding blood: median [IQR] = 0.20 [0.04\u20131.18] vs 4.9 [3.0\u20138.3], p&lt;0.001. Correlation between blood and pleural fluid NLR in MPE patients was moderate (r\n                    <jats:sub>s<\/jats:sub>\n                    = 0.321, p&lt;0.001). In univariate analysis, NLR (&gt;0.745)) in malignant pleural fluid was predictive of poorer survival (HR = 1.698 [1.0054\u20132.736]; p = 0.030), and remained significant after adjustment for age, sex, presence of a chest drain, cancer type, concurrent infection and subsequent treatment with chemotherapy (HR = 1.786 [1.089\u20132.928]; p = 0.022). Patients with pleural fluid NLR &gt; 0.745 had a significantly shorter median survival of 130 (95% CI 0\u2013282) days compared to 312 (95% CI 195\u2013428) days for pleural NLR &lt; 0.745, p = 0.026. The NLR in blood was also predictive of poorer survival in MPE patients (HR = 1.959 [1.019\u20133.096]; p&lt;0.001). The proportion of neutrophils in pleural fluid was predictive of prognosis more strongly than lymphocytes. This study provides evidence that NLR in malignant effusions can predict survival, and therefore may provide prognostic information for this cohort. This prognostic association in the fluid is driven by the presence of neutrophils.\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0250628","type":"journal-article","created":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T13:35:20Z","timestamp":1619444120000},"page":"e0250628","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-1819","authenticated-orcid":true,"given":"Natalia","family":"Popowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Min","family":"Cheah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8872-588X","authenticated-orcid":true,"given":"Alina","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-9395","authenticated-orcid":true,"given":"Jenette","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,26]]},"reference":[{"issue":"12","key":"pone.0250628.ref001","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"AO Clive","year":"2014","journal-title":"Thorax"},{"issue":"Suppl 2","key":"pone.0250628.ref002","first-page":"ii32","article-title":"Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Group BTSPDG","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"pone.0250628.ref003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12890-015-0025-z","article-title":"Important prognostic factors for survival in patients with malignant pleural effusion","volume":"15","author":"MM Zamboni","year":"2015","journal-title":"BMC Pulm Med"},{"issue":"1","key":"pone.0250628.ref004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.117.1.79","article-title":"Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions","volume":"117","author":"JE Heffner","year":"2000","journal-title":"Chest"},{"issue":"4","key":"pone.0250628.ref005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000356764","article-title":"Prognostic factors in patients presenting with pleural effusion revealing malignancy","volume":"87","author":"S Anevlavis","year":"2014","journal-title":"Respiration"},{"issue":"23","key":"pone.0250628.ref006","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1158\/1078-0432.CCR-10-2245","article-title":"High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy","volume":"16","author":"SC Kao","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"3","key":"pone.0250628.ref007","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"DJ Pinato","year":"2012","journal-title":"J Thorac Oncol"},{"key":"pone.0250628.ref008","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"SH Jafri","year":"2013","journal-title":"BMC Cancer"},{"issue":"11","key":"pone.0250628.ref009","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s12094-012-0872-5","article-title":"Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer","volume":"14","author":"S Cedres","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"pone.0250628.ref010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.exer.2011.08.003","article-title":"Endothelial mesenchymal transformation mediated by IL-1beta-induced FGF-2 in corneal endothelial cells","volume":"95","author":"JG Lee","year":"2012","journal-title":"Exp Eye Res"},{"issue":"1","key":"pone.0250628.ref011","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4048\/jbc.2013.16.1.55","article-title":"Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients","volume":"16","author":"H Noh","year":"2013","journal-title":"J Breast Cancer"},{"issue":"6","key":"pone.0250628.ref012","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"AJ Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"pone.0250628.ref013","doi-asserted-by":"crossref","first-page":"7057","DOI":"10.1200\/jco.2011.29.15_suppl.7057","article-title":"PI3K pathway and downstream signaling analysis in malignant pleural mesothelioma (MPM)","volume":"29 suppl","author":"SC Perez","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"pone.0250628.ref014","first-page":"2179","article-title":"Pleural Neutrophil-to-Lymphocyte Ratio May Be Associated With Early Disease Progression in Stage IV Non-small Cell Lung Cancer","volume":"34","author":"JU Lim","year":"2020","journal-title":"In vivo (Athens, Greece)"},{"issue":"4","key":"pone.0250628.ref015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/0003-4819-77-4-507","article-title":"Pleural effusions: the diagnostic separation of transudates and exudates","volume":"77","author":"RW Light","year":"1972","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0250628.ref016","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199107183250305","article-title":"Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer","volume":"325","author":"J Crawford","year":"1991","journal-title":"N Engl J Med"},{"key":"pone.0250628.ref017","article-title":"AHFS drug information","author":"GK McEvoy","year":"2012","journal-title":"Bethesda (MD): American Society of Health-System Pharmacists"},{"issue":"1","key":"pone.0250628.ref018","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.critrevonc.2013.03.010","article-title":"The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer","volume":"88","author":"GJ Guthrie","year":"2013","journal-title":"Critical reviews in oncology\/hematology"},{"issue":"3","key":"pone.0250628.ref019","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s10120-010-0554-3","article-title":"High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer","volume":"13","author":"H Shimada","year":"2010","journal-title":"Gastric Cancer"},{"issue":"6","key":"pone.0250628.ref020","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/1354750X.2010.491557","article-title":"Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer","volume":"15","author":"X An","year":"2010","journal-title":"Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals"},{"issue":"2","key":"pone.0250628.ref021","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jtcvs.2008.05.046","article-title":"Neutrophil\/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer","volume":"137","author":"KM Sarraf","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"pone.0250628.ref022","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bjc.6602702","article-title":"Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model","volume":"93","author":"H Schmidt","year":"2005","journal-title":"Br J Cancer"},{"key":"pone.0250628.ref023","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12885-015-1599-9","article-title":"Neutrophil count is associated with survival in localized prostate cancer","volume":"15","author":"H Bahig","year":"2015","journal-title":"BMC Cancer"},{"issue":"12","key":"pone.0250628.ref024","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hed.22008","article-title":"Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma","volume":"34","author":"JR He","year":"2012","journal-title":"Head Neck"},{"issue":"3","key":"pone.0250628.ref025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600768","article-title":"Metastatic renal carcinoma comprehensive prognostic system","volume":"88","author":"Group DGCRCC-IT","year":"2003","journal-title":"Br J Cancer"},{"issue":"11","key":"pone.0250628.ref026","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ejca.2009.01.023","article-title":"Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03","volume":"45","author":"S Teramukai","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"pone.0250628.ref027","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12307-014-0147-5","article-title":"The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment","volume":"8","author":"RV Sionov","year":"2015","journal-title":"Cancer Microenviron"},{"issue":"4","key":"pone.0250628.ref028","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00063198-200207000-00009","article-title":"Vascular endothelial growth factor: the key mediator in pleural effusion formation","volume":"8","author":"CS Grove","year":"2002","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"pone.0250628.ref029","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rmed.2010.10.010","article-title":"Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma","volume":"105","author":"N Hirayama","year":"2011","journal-title":"Respir Med"},{"issue":"4","key":"pone.0250628.ref030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.102.4.1055","article-title":"Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity","volume":"102","author":"A Yokoyama","year":"1992","journal-title":"Chest"},{"issue":"2","key":"pone.0250628.ref031","first-page":"367","article-title":"Interleukin 8: an autocrine growth factor for malignant mesothelioma","volume":"59","author":"G Galffy","year":"1999","journal-title":"Cancer Res"},{"key":"pone.0250628.ref032","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3389\/fimmu.2015.00471","article-title":"How Neutrophils Shape Adaptive Immune Responses","volume":"6","author":"PH Leliefeld","year":"2015","journal-title":"Frontiers in immunology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T13:36:01Z","timestamp":1619444161000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250628"}},"subtitle":[],"editor":[{"given":"Luka","family":"Brcic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,26]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0250628","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,26]]}}}